13/01/23 - Events
The meeting, a success in terms of participation with more than 120 registered participants, has served to analyze the activity of the program and the strategic lines of growth.
The Cancer Research Program of the Hospital del Mar Medical Research Institute held its annual meeting this morning, during which the main lines of the program were analyzed and the main challenges for the future were discussed. The initiative has been a success, with more than 120 people registered in the Josep Marull Room.
The director of the Program and head of the Medical Oncology Service of the Hospital del Mar, Dr. Joan Albanell, stressed that "the program's research has reached a very high level of scientific production and transfer, leading large European projects with the aim of improving the survival of cancer patients". In this sense, some of the presentations made at the meeting analyzed the effort to attract research talent, as well as research into cancer stem cells in solid tumors and hematological cancers and the use of immunotherapy and personalized medicine in breast cancer. Also discussed was personalized medicine in digestive cancer and the work of two of the program's emerging groups, focused on the tumor microenvironment and the incidence of microbiota.
The meeting also included a presentation by Dr. Manuel Valiente, coordinator of the CNIO Brain Metastasis Group, who analyzed strategies to address lethality in mice and humans in this pathology.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
